ANI Pharmaceuticals Inc (ANIP) — Free Cash Flow Generation Index
ANI Pharmaceuticals Inc (ANIP) has a Free Cash Flow Generation Index of 0.21x as of December 2025. Free cash flow of $6.51 Million represents 0% of operating cash flow ($30.37 Million). See ANIP current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
ANI Pharmaceuticals Inc Free Cash Flow Generation Index (2007–2025)
Historical FCF Generation Index trend for ANI Pharmaceuticals Inc across 12 annual periods. Explore ANI Pharmaceuticals Inc (ANIP) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for ANI Pharmaceuticals Inc (2007–2025)
Year-by-year Free Cash Flow Generation Index for ANI Pharmaceuticals Inc. For the full company profile including market capitalisation, see how much is ANI Pharmaceuticals Inc worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.93x | $171.39 Million | $185.22 Million | $13.84 Million | ▲ +25.9% |
| 2024 | 0.74x | $47.06 Million | $64.02 Million | $16.95 Million | ▼ -12.9% |
| 2023 | 0.84x | $100.45 Million | $118.96 Million | $18.51 Million | ▲ +113.8% |
| 2021 | -6.12x | $-20.32 Million | $3.32 Million | $23.64 Million | ▼ -76.0% |
| 2020 | -3.48x | $-53.05 Million | $15.27 Million | $68.32 Million | ▼ -977.0% |
| 2019 | 0.40x | $18.08 Million | $45.63 Million | $27.55 Million | ▼ -52.7% |
| 2018 | 0.84x | $56.16 Million | $67.07 Million | $10.91 Million | ▲ +148.1% |
| 2017 | -1.74x | $-68.57 Million | $39.42 Million | $107.99 Million | ▲ +60.7% |
| 2016 | -4.43x | $-121.59 Million | $27.47 Million | $149.06 Million | ▼ -395.5% |
| 2015 | -0.89x | $-15.42 Million | $17.26 Million | $32.68 Million | ▼ -43.4% |
| 2014 | -0.62x | $-13.72 Million | $22.03 Million | $35.75 Million | ▼ -164.9% |
| 2007 | 0.96x | $710.56K | $739.99K | $29.43K | — |